Any insights gained from these studies will further our understanding of the MBTPS2 properties in disease, and thereby assist in the possibility of utilizing MBTPS2 as a therapeutic target for the treatment of its associated skin disorders and OI. The gene discussed is MBTPS2; the disease is osteogenesis imperfecta.